Deal supported by Xplico

By |November, 2015|

ObsEva and Kissei Pharmaceutical Announce Global Agreement to Develop and Commercialize KLH-2109 for the Treatment of Endometriosis.

Deal supported by Xplico

By |November, 2015|

Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes.

Deal supported by Xplico

By |October, 2015|

Nuevolution Announces Drug Discovery Collaboration with Johnson & Johnson Innovation.

Deal supported by Xplico

By |August, 2015|

PharmaMar announces license agreement with Specialised Therapeutics Australia Pty for
APLIDIN® (plitidepsin) in oncology.

Deal supported by Xplico

By |August, 2015|

Inovio Pharmaceuticals enters into Strategic Cancer Vaccine Collaboration and License Agreement with MedImmune

Deal supported by Xplico

By |July, 2015|

PharmaMar announces license agreement with TTY Biopharm for APLIDIN® (plitidepsin) in hematological cancers

Deal supported by Xplico

By |June, 2015|

LEO Pharma Enters Supply and Distribution Agreement with NeoPharm on Non-Prescription Skin Care Solutions

Xplico launchs Xplico Consolidation – a company valuation tool to support funding & M&A activities

By |June, 2015|

We are pleased to announce that we have released the first version of the Xplico Evaluator consolidation module Xplico Consolidation. The consolidation module enables you in a very easy way to get the company valuation […]

Deal supported by Xplico

By |May, 2015|

arGEN-X and LEO Pharma Enter into Alliance to Develop Antibody-based Treatments for Skin Conditions

Deal supported by Xplico

By |April, 2015|

HRA Pharma Closes Investment in Embera NeuroTherapeutics to Advance Development of Novel Therapies for Addiction